Gilead Sciences (GILD) Tops Q1 EPS by 4c; maintains guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $152.95 -2.27%
EPS Growth %: -12.1%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -12.1%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.81, $0.04 better than the analyst estimate of $1.77. Revenue for the quarter came in at $6.67 billion versus the consensus estimate of $6.78 billion.
GUIDANCE:
Gilead Sciences sees FY2025 EPS of $7.70-$8.10, versus the consensus of $7.95. Gilead Sciences sees FY2025 revenue of $28.2-28.6 billion, versus the consensus of $28.729 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin's Aide Says War In Ukraine Moving Toward An End - Vesti
- First Community Corp. (FCCO) Tops Q3 EPS by 5c
- NeOnc expands Abu Dhabi program, schedules FDA meeting for NEO212
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
